What is the address of DR.SLAUS MANU,ALGEMENE GENEESKUNDE?

The registered office of DR.SLAUS MANU,ALGEMENE GENEESKUNDE is located at Langeveldstraat 91, 1745 Opwijk.

Is DR.SLAUS MANU,ALGEMENE GENEESKUNDE still active?

Yes. According to the CBE (29 September 2026) DR.SLAUS MANU,ALGEMENE GENEESKUNDE is active, legal situation “Normale toestand”, started on 1 December 2006.

Is DR.SLAUS MANU,ALGEMENE GENEESKUNDE registered on Peppol?

Yes, DR.SLAUS MANU,ALGEMENE GENEESKUNDE is registered on the Peppol network with ID 0208:0885387492.

What is the enterprise number of DR.SLAUS MANU,ALGEMENE GENEESKUNDE?

The enterprise number of DR.SLAUS MANU,ALGEMENE GENEESKUNDE is BE0885387492.

When was DR.SLAUS MANU,ALGEMENE GENEESKUNDE founded?

DR.SLAUS MANU,ALGEMENE GENEESKUNDE was founded on 1 December 2006.

Who are the directors of DR.SLAUS MANU,ALGEMENE GENEESKUNDE?

According to the 2025 annual accounts, the directors of DR.SLAUS MANU,ALGEMENE GENEESKUNDE are: Manu Slaus.

Is DR.SLAUS MANU,ALGEMENE GENEESKUNDE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 December 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR.SLAUS MANU,ALGEMENE GENEESKUNDE make in 2025?

DR.SLAUS MANU,ALGEMENE GENEESKUNDE recorded a loss after taxes of € 17,550 in financial year 2025.

What is the revenue of DR.SLAUS MANU,ALGEMENE GENEESKUNDE?

As a small company, DR.SLAUS MANU,ALGEMENE GENEESKUNDE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 47,540.

DR.SLAUS MANU,ALGEMENE GENEESKUNDE (Private Limited)

Dossier DR.SLAUS MANU,ALGEMENE GENEESKUNDE, printed on 29 September 2026 from databakkes.be/en/0885387492/dr-slaus-manu-algemene-geneeskunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

DR.SLAUS MANU,ALGEMENE GENEESKUNDE from Opwijk, company number BE0885387492, closed financial year 2025 with a result of € -17,550 after tax. For that financial year DR.SLAUS MANU,ALGEMENE GENEESKUNDE recorded a gross margin of € 47,540 and equity of € 95,876. Compared with financial year 2024, the result moved from € -14,690 to € -17,550. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.

What it is worth Healthy

€ 95,876

▼ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -17,550

▼ 19 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 57,699

▲ € 52,833 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 83,476.

People and assets in 2025

Vehicles and equipment

€ 100,648

▼ 35% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 125,547

▼ 25% vs 2024

€ 42,830 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 5,978

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 593

▲ 116% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -24,076 Gross margin 2022: € -24,076 First fiscal year in the series	€ 74,166 Gross margin 2023: € 74,166 ▲ € 98,242 vs 2022 (€ -24,076) Favourable step	€ 20,009 Gross margin 2024: € 20,009 ▼ 73% vs 2023 (€ 74,166) Unfavourable step	€ 47,540 Gross margin 2025: € 47,540 ▲ 138% vs 2024 (€ 20,009) Favourable step	▲ 138%
Profit after taxes	€ -57,394 Profit after taxes 2022: € -57,394 First fiscal year in the series	€ 29,842 Profit after taxes 2023: € 29,842 ▲ € 87,236 vs 2022 (€ -57,394) Favourable step	€ -14,690 Profit after taxes 2024: € -14,690 ▼ € 44,532 vs 2023 (€ 29,842) Unfavourable step	€ -17,550 Profit after taxes 2025: € -17,550 ▼ € 2,860 vs 2024 (€ -14,690) Unfavourable step	▼ € 2,860
Equity	€ 98,274 Equity 2022: € 98,274 First fiscal year in the series	€ 128,116 Equity 2023: € 128,116 ▲ 30% vs 2022 (€ 98,274) Favourable step	€ 113,426 Equity 2024: € 113,426 ▼ 11% vs 2023 (€ 128,116) Unfavourable step	€ 95,876 Equity 2025: € 95,876 ▼ 15% vs 2024 (€ 113,426) Unfavourable step	▼ 15%
Total debts	€ 148,356 Total debts 2022: € 148,356 First fiscal year in the series	€ 100,279 Total debts 2023: € 100,279 ▼ 32% vs 2022 (€ 148,356) Favourable step	€ 189,938 Total debts 2024: € 189,938 ▲ 89% vs 2023 (€ 100,279) Unfavourable step	€ 154,538 Total debts 2025: € 154,538 ▼ 19% vs 2024 (€ 189,938) Favourable step	▼ 19%
Cash	€ 29,078 Cash 2022: € 29,078 First fiscal year in the series	€ 53,314 Cash 2023: € 53,314 ▲ 83% vs 2022 (€ 29,078) Favourable step	€ 4,866 Cash 2024: € 4,866 ▼ 91% vs 2023 (€ 53,314) Unfavourable step	€ 57,699 Cash 2025: € 57,699 ▲ € 52,833 vs 2024 (€ 4,866) Favourable step	▲ € 52,833
Retained profit	€ 85,874 Retained profit 2022: € 85,874 First fiscal year in the series	€ 115,716 Retained profit 2023: € 115,716 ▲ 35% vs 2022 (€ 85,874) Favourable step	€ 101,026 Retained profit 2024: € 101,026 ▼ 13% vs 2023 (€ 115,716) Unfavourable step	€ 83,476 Retained profit 2025: € 83,476 ▼ 17% vs 2024 (€ 101,026) Unfavourable step	▼ 17%
Bank debt	€ 117,769 Bank debt 2022: € 117,769 First fiscal year in the series	€ 89,560 Bank debt 2023: € 89,560 ▼ 24% vs 2022 (€ 117,769) Favourable step	€ 167,159 Bank debt 2024: € 167,159 ▲ 87% vs 2023 (€ 89,560) Unfavourable step	€ 125,547 Bank debt 2025: € 125,547 ▼ 25% vs 2024 (€ 167,159) Favourable step	▼ 25%
Balance sheet total	€ 246,630 Balance sheet total 2022: € 246,630 First fiscal year in the series	€ 228,396 Balance sheet total 2023: € 228,396 ▼ 7% vs 2022 (€ 246,630) Unchanged	€ 303,364 Balance sheet total 2024: € 303,364 ▲ 33% vs 2023 (€ 228,396) Unchanged	€ 250,414 Balance sheet total 2025: € 250,414 ▼ 17% vs 2024 (€ 303,364) Unchanged	▼ 17%

Key figures of DR.SLAUS MANU,ALGEMENE GENEESKUNDE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR.SLAUS MANU,ALGEMENE GENEESKUNDE?

What happened at DR.SLAUS MANU,ALGEMENE GENEESKUNDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2026 Manu Slaus stepped down as director. NBB
Aug 30, 2026 New annual accounts for financial year 2025: loss of € 17,550. filed late Source: NBB ↗
2016 Manu Slaus became a director. NBB
Dec 1, 2006 Start of the company according to the CBE. KBO

In short

From € 57,394 loss in 2022 to € 17,550 loss in 2025.

Paid € 3,794 in corporate taxes since 2022.

Best year ever: 2023, with € 29,842 profit.

Original PDFs at the National Bank ↗

A new publication or filing at DR.SLAUS MANU,ALGEMENE GENEESKUNDE? We notify you, reason included.

Follow DR.SLAUS MANU,ALGEMENE GENEESKUNDE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Directors

According to the 2025 annual accounts

Manu Slaus

Director

since 2016 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Langeveldstraat 91

1745 Opwijk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0885.387.492
VAT number: BE 0885.387.492
Registered office: Langeveldstraat 91, 1745 Opwijk
Names & denominations: DR.SLAUS MANU,ALGEMENE GENEESKUNDE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 December 2006
Peppol: Active · Active since 27 Mar 2026

View on CBE Public ↗ Annual accounts (NBB) ↗

DR.SLAUS MANU,ALGEMENE GENEESKUNDE